Cristina L. Abrahams

Author

Sutro Biopharma (United States)ORCID

Also Known As

C Abrahams, C. Abrahams, Cristina Abrahams, Cristina L. Abrahams, Cristina Luna Abrahams

Publications

455

Citations

H-Index

Concepts

All Affiliations

Sutro Biopharma (United States)Fred Hutch Cancer Center Applied Biomathematics (United States)Children's Oncology Group University of Washington

About

Cristina L. Abrahams is an author at Sutro Biopharma (United States) specializing in immunotherapy, medicine, and antibody engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	99
2	Immunology	3	3	45
3	Obstetrics	2	2	65
4	Natural Sciences	1	1	54
5	Cell Biology	1	1	15

Cristina L. Abrahams

Publications

412

Citations

H-Index

Page 1

	Year	Citations
Alk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of Notch Irene M. Aspalter, Emma Gordon, Alexandre Dubrac, Nature Communications	2015	166
Functional Consequences of Wnt-induced Dishevelled 2 Phosphorylation in Canonical and Noncanonical Wnt Signaling José Manuel González‐Sancho, Yoshimi Endo Greer, Cristina L. Abrahams, Journal of Biological Chemistry	2013	73
Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial Cancers Xiaofan Li, Sihong Zhou, Cristina L. Abrahams, Molecular Cancer Therapeutics Drug TargetGynecologyPeptide ScienceImmunotherapeuticsEndometrial Cancers	2022	54
Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001 Cristina L. Abrahams, Xiaofan Li, Millicent Embry, Oncotarget	2018	51
Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1–antibody-drug conjugate Thao T. Tang, Quy Le, Sommer Castro, Blood Advances MedicineImmunologyImmune SurveillanceAntibody EngineeringImmunotherapy	2022	19
Preclinical studies targeting CD74 with STRO-001 antibody-drug conjugate in acute leukemia Quy Le, Thao T. Tang, Amanda R. Leonti, Blood Advances Hematological MalignancyMedicinePreclinical StudiesMalignant Blood DisorderImmunology	2023	15
Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001 Xiaofan Li, Cristina L. Abrahams, Abigail Yu, Oncotarget	2023	13
Abstract 1782: Discovery and activity of STRO-002, a novel ADC targeting folate receptor alpha for ovarian and endometrial cancer Xiaofan Li, Cristina L. Abrahams, Sihong Zhou, Cancer Research ImmunologyGynecologyImmunotherapeuticsTumor BiologyOvarian Cancer	2018	11
Targeting CD74 with Novel Antibody Drug Conjugates (ADCs) for the Treatment of B-Cell Non-Hodgkin's Lymphoma (NHL) Xiaofan Li, Cristina L. Abrahams, Millicent Embry, Blood	2016	10

Page 1